Form 8-K - Current report:
SEC Accession No. 0001564590-21-031601
Filing Date
2021-06-03
Accepted
2021-06-03 17:00:21
Documents
12
Period of Report
2021-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20210603.htm   iXBRL 8-K 68893
  Complete submission text file 0001564590-21-031601.txt   200005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srpt-20210603.xsd EX-101.SCH 5820
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20210603_lab.xml EX-101.LAB 19493
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20210603_pre.xml EX-101.PRE 11663
5 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20210603_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 21993305
SIC: 2834 Pharmaceutical Preparations